These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25643074)

  • 1. Structure-activity relationship studies and in vivo activity of guanidine-based sphingosine kinase inhibitors: discovery of SphK1- and SphK2-selective inhibitors.
    Patwardhan NN; Morris EA; Kharel Y; Raje MR; Gao M; Tomsig JL; Lynch KR; Santos WL
    J Med Chem; 2015 Feb; 58(4):1879-1899. PubMed ID: 25643074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming Sphingosine Kinase 1 Inhibitors into Dual and Sphingosine Kinase 2 Selective Inhibitors: Design, Synthesis, and in Vivo Activity.
    Childress ES; Kharel Y; Brown AM; Bevan DR; Lynch KR; Santos WL
    J Med Chem; 2017 May; 60(9):3933-3957. PubMed ID: 28406646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationship studies of the lipophilic tail region of sphingosine kinase 2 inhibitors.
    Congdon MD; Childress ES; Patwardhan NN; Gumkowski J; Morris EA; Kharel Y; Lynch KR; Santos WL
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4956-4960. PubMed ID: 25862200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingosine kinase type 2 inhibition elevates circulating sphingosine 1-phosphate.
    Kharel Y; Raje M; Gao M; Gellett AM; Tomsig JL; Lynch KR; Santos WL
    Biochem J; 2012 Oct; 447(1):149-57. PubMed ID: 22747486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a Small Side Cavity in Sphingosine Kinase 2 that Enhances Inhibitor Potency and Selectivity.
    Sibley CD; Morris EA; Kharel Y; Brown AM; Huang T; Bevan DR; Lynch KR; Santos WL
    J Med Chem; 2020 Feb; 63(3):1178-1198. PubMed ID: 31895563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugging sphingosine kinases.
    Santos WL; Lynch KR
    ACS Chem Biol; 2015 Jan; 10(1):225-33. PubMed ID: 25384187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a Potent and Selective Sphingosine Kinase 1 Inhibitor through the Molecular Combination of Chemotype-Distinct Screening Hits.
    Schnute ME; McReynolds MD; Carroll J; Chrencik J; Highkin MK; Iyanar K; Jerome G; Rains JW; Saabye M; Scholten JA; Yates M; Nagiec MM
    J Med Chem; 2017 Mar; 60(6):2562-2572. PubMed ID: 28231433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the substitution pattern of indole-based scaffold reveals potent and selective sphingosine kinase 2 inhibitors.
    Congdon M; Fritzemeier RG; Kharel Y; Brown AM; Serbulea V; Bevan DR; Lynch KR; Santos WL
    Eur J Med Chem; 2021 Feb; 212():113121. PubMed ID: 33445156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosine kinase inhibitors: a review of patent literature (2006-2015).
    Lynch KR; Thorpe SB; Santos WL
    Expert Opin Ther Pat; 2016 Dec; 26(12):1409-1416. PubMed ID: 27539678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine kinase 2 inhibitor SG-12 induces apoptosis via phosphorylation by sphingosine kinase 2.
    Hara-Yokoyama M; Terasawa K; Ichinose S; Watanabe A; Podyma-Inoue KA; Akiyoshi K; Igarashi Y; Yanagishita M
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2220-4. PubMed ID: 23434415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen.
    Schröder M; Richter C; Juan MH; Maltusch K; Giegold O; Quintini G; Pfeilschifter JM; Huwiler A; Radeke HH
    Mol Immunol; 2011 May; 48(9-10):1139-48. PubMed ID: 21435724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational design of SphK inhibitors using crystal structures aided by computer.
    Ding T; Zhi Y; Xie W; Yao Q; Liu B
    Eur J Med Chem; 2021 Mar; 213():113164. PubMed ID: 33454547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipophilic tail modifications of 2-(hydroxymethyl)pyrrolidine scaffold reveal dual sphingosine kinase 1 and 2 inhibitors.
    Li H; Sibley CD; Kharel Y; Huang T; Brown AM; Wonilowicz LG; Bevan DR; Lynch KR; Santos WL
    Bioorg Med Chem; 2021 Jan; 30():115941. PubMed ID: 33385956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosine kinase inhibitors: A patent review.
    Cao M; Ji C; Zhou Y; Huang W; Ni W; Tong X; Wei JF
    Int J Mol Med; 2018 May; 41(5):2450-2460. PubMed ID: 29484372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure guided design of a series of sphingosine kinase (SphK) inhibitors.
    Gustin DJ; Li Y; Brown ML; Min X; Schmitt MJ; Wanska M; Wang X; Connors R; Johnstone S; Cardozo M; Cheng AC; Jeffries S; Franks B; Li S; Shen S; Wong M; Wesche H; Xu G; Carlson TJ; Plant M; Morgenstern K; Rex K; Schmitt J; Coxon A; Walker N; Kayser F; Wang Z
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4608-16. PubMed ID: 23845219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine Kinase 2 Inhibition and Blood Sphingosine 1-Phosphate Levels.
    Kharel Y; Morris EA; Congdon MD; Thorpe SB; Tomsig JL; Santos WL; Lynch KR
    J Pharmacol Exp Ther; 2015 Oct; 355(1):23-31. PubMed ID: 26243740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Building a better sphingosine kinase-1 inhibitor.
    Lynch KR
    Biochem J; 2012 May; 444(1):e1-2. PubMed ID: 22533672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingosine Kinase 2 Inhibitors: Rigid Aliphatic Tail Derivatives Deliver Potent and Selective Analogues.
    Pashikanti S; Foster DJ; Kharel Y; Brown AM; Bevan DR; Lynch KR; Santos WL
    ACS Bio Med Chem Au; 2022 Oct; 2(5):469-489. PubMed ID: 36281302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of cellular S1P levels with a novel, potent and specific inhibitor of sphingosine kinase-1.
    Schnute ME; McReynolds MD; Kasten T; Yates M; Jerome G; Rains JW; Hall T; Chrencik J; Kraus M; Cronin CN; Saabye M; Highkin MK; Broadus R; Ogawa S; Cukyne K; Zawadzke LE; Peterkin V; Iyanar K; Scholten JA; Wendling J; Fujiwara H; Nemirovskiy O; Wittwer AJ; Nagiec MM
    Biochem J; 2012 May; 444(1):79-88. PubMed ID: 22397330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pachastrissamine (jaspine B) and its stereoisomers inhibit sphingosine kinases and atypical protein kinase C.
    Yoshimitsu Y; Oishi S; Miyagaki J; Inuki S; Ohno H; Fujii N
    Bioorg Med Chem; 2011 Sep; 19(18):5402-8. PubMed ID: 21868240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.